Alessandro Roggeri1, Daniela Paola Roggeri2, Carlo Zocchetti3, Maurizio Bersani3, Ferruccio Conte4. 1. Health Economics, ProCure Solutions, Via Camozzi 1/c, 24027, Nembro, Bergamo, Italy. alessandro.roggeri@procuresolutions.it. 2. Health Economics, ProCure Solutions, Via Camozzi 1/c, 24027, Nembro, Bergamo, Italy. 3. Regional Health Authority, Lombardy Region, Milan, Italy. 4. Nephrology Unit, S. Uboldo Hospital, Cernusco sul Naviglio, Italy.
Abstract
BACKGROUND: Chronic kidney disease (CKD) progression is associated with significant comorbidities and costs. In Italy, limited evidence of healthcare resource consumption and costs is available. We therefore aimed to investigate the direct healthcare costs in charge to the Lombardy Regional Health Service (RHS) for the treatment of CKD patients in the first year after starting hemodialysis and in the 2 years prior to dialysis. METHODS: Citizens resident in the Lombardy Region (Italy) who initiated dialysis in the year 2011 (Jan 1 to Dec 31) were selected and data were extracted from Lombardy Regional databases on their direct healthcare costs in the first year after starting dialysis and in the 2 years prior to it was analyzed. Drugs, hospitalizations, diagnostic procedures and outpatient costs covered by RHS were estimated. Patients treated for acute kidney injury, or who died or stopped dialysis during the observational period were excluded. RESULTS: From the regional population (>9,700,000 inhabitants), 1067 patients (34.3 % females) initiating dialysis were identified, of whom 82 % underwent only hemodialysis (HD), 13 % only peritoneal dialysis (PD) and the remaining 5 % both treatments. Direct healthcare costs/patient were € 5239, € 12,303 and € 38,821 (€ 40,132 for HD vs. € 30,444 for PD patients) for the periods 24-12 months pre-dialysis, 12-0 months pre-dialysis, and in the first year of dialysis, respectively. CONCLUSIONS: This study highlights a significant economic burden related to CKD and an increase in direct healthcare costs associated with the start of dialysis, pointing to the importance of prevention programs and early diagnosis.
BACKGROUND:Chronic kidney disease (CKD) progression is associated with significant comorbidities and costs. In Italy, limited evidence of healthcare resource consumption and costs is available. We therefore aimed to investigate the direct healthcare costs in charge to the Lombardy Regional Health Service (RHS) for the treatment of CKDpatients in the first year after starting hemodialysis and in the 2 years prior to dialysis. METHODS: Citizens resident in the Lombardy Region (Italy) who initiated dialysis in the year 2011 (Jan 1 to Dec 31) were selected and data were extracted from Lombardy Regional databases on their direct healthcare costs in the first year after starting dialysis and in the 2 years prior to it was analyzed. Drugs, hospitalizations, diagnostic procedures and outpatient costs covered by RHS were estimated. Patients treated for acute kidney injury, or who died or stopped dialysis during the observational period were excluded. RESULTS: From the regional population (>9,700,000 inhabitants), 1067 patients (34.3 % females) initiating dialysis were identified, of whom 82 % underwent only hemodialysis (HD), 13 % only peritoneal dialysis (PD) and the remaining 5 % both treatments. Direct healthcare costs/patient were € 5239, € 12,303 and € 38,821 (€ 40,132 for HD vs. € 30,444 for PDpatients) for the periods 24-12 months pre-dialysis, 12-0 months pre-dialysis, and in the first year of dialysis, respectively. CONCLUSIONS: This study highlights a significant economic burden related to CKD and an increase in direct healthcare costs associated with the start of dialysis, pointing to the importance of prevention programs and early diagnosis.
Authors: Chi Pang Wen; Ting Yuan David Cheng; Min Kuang Tsai; Yen Chen Chang; Hui Ting Chan; Shan Pou Tsai; Po Huang Chiang; Chih Cheng Hsu; Pei Kun Sung; Yi Hua Hsu; Sung Feng Wen Journal: Lancet Date: 2008-06-28 Impact factor: 79.321
Authors: A S Levey; R Atkins; J Coresh; E P Cohen; A J Collins; K-U Eckardt; M E Nahas; B L Jaber; M Jadoul; A Levin; N R Powe; J Rossert; D C Wheeler; N Lameire; G Eknoyan Journal: Kidney Int Date: 2007-06-13 Impact factor: 10.612
Authors: Bernadette Li; John A Cairns; James Fotheringham; Charles R Tomson; John L Forsythe; Christopher Watson; Wendy Metcalfe; Damian G Fogarty; Heather Draper; Gabriel C Oniscu; Christopher Dudley; Rachel J Johnson; Paul Roderick; Geraldine Leydon; J Andrew Bradley; Rommel Ravanan Journal: Nephrol Dial Transplant Date: 2015-06-11 Impact factor: 5.992
Authors: Claudio Jommi; Patrizio Armeni; Margherita Battista; Paolo di Procolo; Giuseppe Conte; Claudio Ronco; Mario Cozzolino; Anna Maria Costanzo; Umberto di Luzio Paparatti; Gabriella Concas; Giuseppe Remuzzi Journal: Pharmacoecon Open Date: 2018-12